2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation : The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). / Ibanez, Borja; James, Stefan; Agewall, Stefan; Antunes, Manuel J.; Bucciarelli-Ducci, Chiara; Bueno, Hector; Caforio, Alida L.P.; Crea, Filippo; Goudevenos, John A.; Halvorsen, Sigrun; Hindricks, Gerhard; Kastrati, Adnan; Lenzen, Mattie J.; Prescott, Eva; Roffi, Marco; Valgimigli, Marco; Varenhorst, Christoph; Vranckx, Pascal; Widimský, Petr; Baumbach, Andreas; Bugiardini, Raffaele; Coman, Ioan Mircea; Delgado, Victoria; Fitzsimons, Donna; Gaemperli, Oliver; Gershlick, Anthony H.; Gielen, Stephan; Harjola, Veli Pekka; Katus, Hugo A.; Knuuti, Juhani; Kolh, Philippe; Leclercq, Christophe; Lip, Gregory Y.H.; Morais, Joao; Neskovic, Aleksandar N.; Neumann, Franz Josef; Niessner, Alexander; Piepoli, Massimo Francesco; Richter, Dimitrios J.; Shlyakhto, Evgeny; Simpson, Iain A.; Steg, Ph Gabriel; Terkelsen, Christian Juhl; Thygesen, Kristian; Windecker, Stephan; Zamorano, Jose Luis; Zeymer, Uwe; Chettibi, Mohamed; Hayrapetyan, Hamlet G.; Metzler, Bernhard; ESC National Cardiac Societies.
I: European Heart Journal, Bind 39, Nr. 2, 2018, s. 119-177.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
T2 - The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
AU - Ibanez, Borja
AU - James, Stefan
AU - Agewall, Stefan
AU - Antunes, Manuel J.
AU - Bucciarelli-Ducci, Chiara
AU - Bueno, Hector
AU - Caforio, Alida L.P.
AU - Crea, Filippo
AU - Goudevenos, John A.
AU - Halvorsen, Sigrun
AU - Hindricks, Gerhard
AU - Kastrati, Adnan
AU - Lenzen, Mattie J.
AU - Prescott, Eva
AU - Roffi, Marco
AU - Valgimigli, Marco
AU - Varenhorst, Christoph
AU - Vranckx, Pascal
AU - Widimský, Petr
AU - Baumbach, Andreas
AU - Bugiardini, Raffaele
AU - Coman, Ioan Mircea
AU - Delgado, Victoria
AU - Fitzsimons, Donna
AU - Gaemperli, Oliver
AU - Gershlick, Anthony H.
AU - Gielen, Stephan
AU - Harjola, Veli Pekka
AU - Katus, Hugo A.
AU - Knuuti, Juhani
AU - Kolh, Philippe
AU - Leclercq, Christophe
AU - Lip, Gregory Y.H.
AU - Morais, Joao
AU - Neskovic, Aleksandar N.
AU - Neumann, Franz Josef
AU - Niessner, Alexander
AU - Piepoli, Massimo Francesco
AU - Richter, Dimitrios J.
AU - Shlyakhto, Evgeny
AU - Simpson, Iain A.
AU - Steg, Ph Gabriel
AU - Terkelsen, Christian Juhl
AU - Thygesen, Kristian
AU - Windecker, Stephan
AU - Zamorano, Jose Luis
AU - Zeymer, Uwe
AU - Chettibi, Mohamed
AU - Hayrapetyan, Hamlet G.
AU - Metzler, Bernhard
AU - ESC National Cardiac Societies
PY - 2018
Y1 - 2018
N2 - The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
AB - The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
KW - Acute coronary syndromes
KW - Acute myocardial infarction
KW - Antithrombotic therapy
KW - Antithrombotics
KW - Emergency medical system
KW - Evidence
KW - Fibrinolysis
KW - Guidelines
KW - Ischaemic heart disease
KW - MINOCA
KW - Primary percutaneous coronary intervention
KW - Quality indicators
KW - Reperfusion therapy
KW - Risk assessment
KW - Secondary prevention
KW - ST-segment elevation.
U2 - 10.1093/eurheartj/ehx393
DO - 10.1093/eurheartj/ehx393
M3 - Review
C2 - 28886621
AN - SCOPUS:85040602547
VL - 39
SP - 119
EP - 177
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 2
ER -
ID: 214339278